newsfilter
← Latest News
GlobeNewswire·

BiondVax Presenting at BIO CEO & Investor Conference

JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative